Tracking Post-stroke Walking Improvements From the Clinic Into the Home
該当なし
完了
NCT05454007
| 対象疾患 | Stroke, Healthy Adult |
|---|
| 相 | 該当なし |
|---|
| スポンサー | Western University of Health Sciences |
|---|
| ステータス | 完了 |
|---|
| 参加者数 | 53 名 |
|---|
| 介入(薬剤) | Step length asymmetry training |
|---|
| 開始日 | 2022年8月25日 |
|---|
| 完了日 | 2025年3月9日 |
|---|
| 結果公開日 | 2026年7月24日 |
|---|
概要
The purpose of this proposal is to use novel video-based movement tracking technology to measure gait quality after stroke - in the home. Current rehabilitation practice assesses walking in the highly controlled 'ideal' clinical environment. The implicit assumption by clinicians and researchers is that the way people walk in the clinic (their best capacity) reflects the way they walk in the real-world (true performance). With advances in computer vision and development of pose estimation algorithms, it is now possible to directly measure how people are walking in their homes. It is critical that researchers apply this technology to examine the basic assumptions that underlie current rehabilitation practice. Here, a video-based pose estimation workflow will be used to 1) contrast the gait patterns of persons post-stroke as observed in-clinical vs. in-home settings, and 2) map the rate of deterioration of clinically-derived walking improvements, in the home. This methodology has been used to accurately measure gait kinematics in people with stroke as they walk in laboratory, however this study now seeks to use these methods to record people with stroke as they walk in their natural h
Step Length Asymmetry
In-clinic baseline (day 1), in-home baseline (day 1) · unitless
| Individuals With Stroke | 0.12 ± 0.11 unitless |
|---|
| Neurologically Intact Adults | 0.07 ± 0.07 unitless |
|---|
| Individuals With Stroke | 0.15 ± 0.11 unitless |
|---|
| Neurologically Intact Adults | 0.07 ± 0.04 unitless |
|---|
Step Time Symmetry
In-clinic baseline (day 1), in-home baseline (day 1) · unitless
| Individuals With Stroke | 0.10 ± 0.14 unitless |
|---|
| Neurologically Intact Adults | 0.05 ± 0.07 unitless |
|---|
| Individuals With Stroke | 0.11 ± 0.15 unitless |
|---|
| Neurologically Intact Adults | 0.04 ± 0.02 unitless |
|---|
Self Selected Gait Speed
In-clinic baseline (day 1), in-home baseline (day 1) · m/s
| Individuals With Stroke | 0.70 ± 0.38 m/s |
|---|
| Neurologically Intact Adults | 1.01 ± 0.28 m/s |
|---|
| Individuals With Stroke | 0.73 ± 0.47 m/s |
|---|
| Neurologically Intact Adults | 1.07 ± 0.64 m/s |
|---|
BENITIONS で見る
ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
すべての治験
このページは ClinicalTrials.gov の公開データをまとめたものです。医学的助言ではなく、投資助言でもありません。必ず専門医にご相談ください。